Clinical Trials Logo
  1. Home
  2. Corneal Dystrophy
  3. NCT05927740

The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in Pregnancy

Corneal Dystrophy Clinical Trial

Official title:
The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in Pregnancy

Clinical Trial Summary

Aim Physiological changes in intraocular pressure as well as in the cornea and macula may occur during pregnancy. In the literature, there are limited data on ocular findings in hyperemesis gravidarum. Therefore, we have decided to investigate the effect of hyperemesis gravidarum on macular thickness, corneal thickness and intraocular pressure (IOP).

Clinical Trial Description

A total of 110 people, 55 of whom were diagnosed with hyperemesis gravidarum and 55 of whom were in the control group, were included in the study. The inclusion criteria for the study were as follows: First trimester (8-14 weeks of gestation) pregnancy with positive fetal heartbeat and no history of systemic disease; no continuous use of medication; diagnosis of hyperemesis gravidarum (ketonuria and weight > 3 kg or 5% of the body) and the occurrence of less than three vomiting attacks per day with loss of weight; body mass index (BMI) within normal limits; being between the ages of 18 and 40; not drinking alcohol or smoking. A total of 94 patients, 40 of whom were diagnosed with hyperemesis gravidarum and 54 healthy pregnant women, were divided into two groups by recording their age, BMI, laboratory and eye findings. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05927740
Study type Interventional
Source Batman Training and Research Hospital
Contact
Status Completed
Phase N/A
Start date March 10, 2020
Completion date May 11, 2023
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05956535 - Air Optix® Night and Day® Aqua Therapeutic Wear
Completed NCT04484402 - Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells Phase 1/Phase 2
Recruiting NCT03504800 - OCT in Diagnosis of Irregular Corneas
Completed NCT05891106 - AONDA Therapeutic Indication Study I
Recruiting NCT01084850 - Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects N/A
Recruiting NCT04129021 - Multimodal Ophthalmic Imaging N/A
Recruiting NCT03461991 - Correlation Between In-vivo Anatomy of Corneal Dystrophies as Assessed by High- Resolution Optical Coherence Tomography (OCT) Measurement and Histological Examination N/A
Not yet recruiting NCT04384094 - Defining the Operating Parameters for a Rebound-esthesiometer
Completed NCT04424550 - Comparative Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy
Enrolling by invitation NCT02746055 - Study of the Prevalence of TGFBI Corneal Dystrophies N/A
Not yet recruiting NCT02736877 - Corneal Transplantation Guided by OCT RESCAN N/A
Completed NCT05279157 - Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD) Phase 2